May 2005
Volume 46, Issue 13
Free
ARVO Annual Meeting Abstract  |   May 2005
Photodynamic Therapy With a New Photosensitizer,Fullerodendrimer, Showed Cytotoxity in Human Umbilical Endothelial Cells
Author Affiliations & Notes
  • H. Nishiwaki
    Ophthalmology &Visual Science, Kyoto University Graduate School of Medicine, Kyoto, Japan
  • N. Yamaike
    Ophthalmology &Visual Science, Kyoto University Graduate School of Medicine, Kyoto, Japan
  • Y. Hirata
    Ophthalmology &Visual Science, Kyoto University Graduate School of Medicine, Kyoto, Japan
  • N. Yoshimura
    Ophthalmology &Visual Science, Kyoto University Graduate School of Medicine, Kyoto, Japan
  • Y. Takaguchi
    Faculty of Environmental Science and Technology, Okayama University, Okayama, Japan
  • Footnotes
    Commercial Relationships  H. Nishiwaki, None; N. Yamaike, None; Y. Hirata, None; N. Yoshimura, None; Y. Takaguchi, None.
  • Footnotes
    Support  None.
Investigative Ophthalmology & Visual Science May 2005, Vol.46, 5389. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      H. Nishiwaki, N. Yamaike, Y. Hirata, N. Yoshimura, Y. Takaguchi; Photodynamic Therapy With a New Photosensitizer,Fullerodendrimer, Showed Cytotoxity in Human Umbilical Endothelial Cells . Invest. Ophthalmol. Vis. Sci. 2005;46(13):5389.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Abstract: : Purpose: Fullerodendrimers consist of fullerens and dendrimers. Fullerens such as C60,produce singlet oxygen effectively with light irradiation. Dendrimers are unique macromolecules with highly branched structures and globular shapes. These characteristics of dendrimers will be useful as drug carriers with target cell specificity. In the present study, we investigated activity of fullerodendrimers to inhibit proliferation of human umbilical endothelial cells(HUVECs) with laser irradiation. Methods: We synthesized the fullerodendrimer,C60(G1.5–COOK), by the use of a Diels–Alder reaction of C60 with anthryl dendron. The fullerodendrimer has an excitation wavelength at 685nm. A semiconductor laser(685nm) was used as the light source for exciting the fullerodendrimer. HUVECs (1.0×104cells/ml)were plated onto 96–well cell culture plates. After 24h incubation, the fullerodendrimer at different concentrations (0–10µg/ml) were added to the 120 wells , then 90 wells were irradiated with 10–30J/cm2 using the semiconductor laser and 30 wells were not irradiated. After 48h incubation,cell viability was determined by a modified MTT assay. Results: The combination of the fullerodendrimer and the laser irradiation decreased the cell viability as a function of laser energy and drug conentrations.The fullerodendrimer at 10µg/ml with the laser irradiation of 10J,20J,30J/cm2 reduced the survival rate to 56.3%(P<0.01), 41.5%(P<0.01),29.8%(P<0.01) of HUVECs respectively. In contrast, the fullerodendrimer alone or the laser irradiation alone showed no cyototoxity in HUVECs. Conclusions: The present study suggests that the fullerodendrimer with the laser irradiation inhibits the proliferation of HUVECs.Fullerodendrimers have a potential to be a new photosensitizer for PDT.

Keywords: drug toxicity/drug effects • pharmacology • laser 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×